Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

CELZ
Creative Medical Technology Holdings, Inc. Common Stock
stock NASDAQ

At Close
Oct 31, 2025 3:59:30 PM EDT
3.19USD-2.599%(-0.09)129,018
0.00Bid   0.00Ask   0.00Spread
Pre-market
Oct 31, 2025 10:26:14 AM EDT
3.18USD-2.752%(-0.09)804
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 3, 2022
02:39PM EST  Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide   Benzinga
12:09PM EST  Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher   Benzinga
10:06AM EST  Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates   Benzinga
07:21AM EST  The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.15 A.M. ET).   RTTNews
Dec 3, 2021
10:15AM EST  Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast   Benzinga
05:30AM EST  Creative Medical Technology Holdings, Inc. (CELZ) on Friday said it has priced its underwritten public offering of 3.87 million shares of common stock and accompanying warrants at a combined price of $4.13, with an expected close on or about December 7.   RTTNews
04:03AM EST  Creative Medical Technology Holdings Prices $16 Mln Public Offering   RTTNews
04:00AM EST  Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering   PR Newswire
Nov 9, 2021
04:46PM EST  Creative Medical Technology Holdings Announces Implementation of Reverse Stock   PR Newswire
Oct 12, 2021
08:19AM EDT  Creative Medical Technology Reports Positive Data On ImmCelz Immunotherapy Product   RTTNews
08:15AM EDT  Creative Medical Technology Holdings Reports Positive Data on ImmCelz(tm)   PR Newswire
Oct 1, 2021
08:20AM EDT  Creative Files Provisional Patent On Type 1 Diabetes Immunotherapy Using Exosomes From MyeloCelz Platform   RTTNews
08:15AM EDT  Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1   PR Newswire
Sep 16, 2021
07:45AM EDT  Creative Medical Technology Holdings, Inc. Engages Established Contact   PR Newswire
Aug 9, 2021
04:44PM EDT  Creative Medical Technology Holdings Announces $3.8 Million Private Placement   PR Newswire
Jul 20, 2021
07:45AM EDT  Creative Medical Technology Holdings Announces MyeloCelz(tm) The Company's   PR Newswire
Jun 22, 2021
07:45AM EDT  Creative Medical Technology Holdings Recruits Renowned Stem Cell Clinical   PR Newswire
Jun 17, 2021
07:01AM EDT  Creative Medical Technology Holdings To Present ImmCelz(r) Subsidiary At World   PR Newswire
Jun 9, 2021
08:19AM EDT  Regenerative Immunotherapy and Myeloid Suppressor Cells in Treatment of Type 1 Diabetes   PR Newswire
May 24, 2021
07:48AM EDT  Creative Medical Technology Announces Positive Data Supporting Extension Of ImmCelz Applicability To Parkinson's Disease   RTTNews
07:45AM EDT  Creative Medical Technology Holdings Expands Neurological Application of   PR Newswire
May 20, 2021
08:46AM EDT  Internationally Renowned Clinician Scientist Camillo Ricordi Head of Diabetes   PR Newswire
May 14, 2021
08:04AM EDT  Creative Medical Technology Reports Receipt Of FDA Response Regarding Necessary Modifications To IND #27375   RTTNews
07:45AM EDT  FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(r)   PR Newswire
Mar 23, 2021
07:45AM EDT  Creative Medical Technology Holdings, Inc. to Launch Virtual Physician(tm)   PR Newswire
Mar 16, 2021
07:18AM EDT  Creative Medical Technology Announces FDA Acknowledgment Of IND Application For ImmCelz To Treat Stroke   RTTNews
07:15AM EDT  Creative Medical Technology Holdings, Inc. Announces FDA Acknowledgment of IND   PR Newswire
Mar 10, 2021
07:45AM EST  Creative Medical Technology Holdings, Inc. Begins Recruitment of StemSpine(r)   PR Newswire
Mar 4, 2021
07:45AM EST  Mobility in Patients with Disc Degenerative Disc Using StemSpine(r) Personalized Adult Stem Cell Therapy   PR Newswire
Mar 3, 2021
07:15AM EST  Creative Medical Technology Holdings Provides Update on ImmCelz(r) FDA   PR Newswire
Feb 16, 2021
07:49AM EST  Creative Medical Technology Holdings Files Patent On Prevention Of Organ Transplant Rejection Using ImmCelz   RTTNews
07:45AM EST  Creative Medical Technology Holdings Files Patent on Prevention of Organ   PR Newswire
Feb 10, 2021
07:45AM EST  Creative Medical Technology Holdings Identifies Cellular Mechanism of Patented   PR Newswire
Feb 8, 2021
07:45AM EST  Creative Medical Technology Holdings Recruits Internationally Renowned Kidney   PR Newswire
Feb 1, 2021
07:45AM EST  Creative Medical Technology Holdings Identifies and Files Patent on Novel   PR Newswire
Jan 27, 2021
07:46AM EST  Creative Medical Technology Holdings Files Patent based on Positive Data on   PR Newswire
Jan 21, 2021
08:15AM EST  Trials Company Dr. Boris Reznik to Accelerate Development of ImmCelz(r) Through FDA   PR Newswire
Jan 20, 2021
08:15AM EST  Leading Urologist Doubles Down on CaverStem(r) Regenerative Stem Cell Procedure   PR Newswire
Jan 19, 2021
07:45AM EST  Creative Medical Technology Holdings Announces Positive Data and Patent Filing   PR Newswire
Jan 12, 2021
08:16AM EST  Creative Medical Files IND With FDA For Treatment Of Stroke Using ImmCelz Regenerative Immunotherapy   RTTNews
08:16AM EST  (IND) with FDA for Treatment of Stroke using ImmCelz(r) Regenerative Immunotherapy   PR Newswire
Jan 6, 2021
07:48AM EST  ImmCelz Stem Cell Component Shows Efficacious In FDA Double Blind Placebo Controlled Trial Of Advanced COVID-19 Patients   RTTNews
07:46AM EST  ImmCelz(r) Stem Cell Component Demonstrated Efficacious in FDA Double Blind   PR Newswire
Dec 31, 2020
08:05AM EST  Creative Medical Technology Holdings announced patent filing based on preclinical data in model of heart attack using immcelz regenerative immunotherapy.   RTTNews
07:48AM EST  Creative Medical Technology Announces Positive Preclinical Data Using ImmCelz In Treatment Of Model Of Heart Attack   RTTNews
07:45AM EST  Preclinical Data in Model of Heart Attack using ImmCelz(r) Regenerative Immunotherapy   PR Newswire
Dec 29, 2020
07:45AM EST  Creative Medical Technology Holdings Announces Reversion of Liver Failure Using   PR Newswire
Dec 22, 2020
07:45AM EST  Creative Medical Technology Holdings Identifies Mechanism of Action of   PR Newswire
Dec 16, 2020
07:52AM EST  Creative Medical Technology Reports Positive Preclinical Data Supporting Utilization Of ImmCelz Cell Based Immunotherapy   RTTNews
07:45AM EST  Creative Medical Technology Holdings Announces Successful Application of   PR Newswire
Dec 10, 2020
07:45AM EST  Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz(r) Cellular Immunotherapy   PR Newswire
Sep 29, 2020
08:15AM EDT  Creative Medical Technology Holdings Reports Positive Preclinical Data on   PR Newswire
Sep 24, 2020
08:50AM EDT  Creative Medical Technology Holdings, Inc. September 2020 Shareholder Update   PR Newswire
Sep 8, 2020
08:15AM EDT  Application of Immunotherapy to $7 Billion Lower Back Pain Market Patented by   PR Newswire
Aug 20, 2020
08:45AM EDT  Creative Medical Technology Holdings Identifies Novel Mechanism of Action of   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC